OPKO Health Share Holder Equity 2010-2024 | OPK
OPKO Health Annual Share Holder Equity (Millions of US $) |
|
---|---|
2023 | $1,389 |
2022 | $1,562 |
2021 | $1,685 |
2020 | $1,672 |
2019 | $1,615 |
2018 | $1,791 |
2017 | $1,844 |
2016 | $2,092 |
2015 | $1,980 |
2014 | $836 |
2013 | $873 |
2012 | $179 |
2011 | $161 |
2010 | $23 |
2009 | $32 |
OPKO Health Quarterly Share Holder Equity (Millions of US $) |
|
---|---|
2024-09-30 | $1,403 |
2024-06-30 | $1,395 |
2024-03-31 | $1,253 |
2023-12-31 | $1,389 |
2023-09-30 | $1,445 |
2023-06-30 | $1,535 |
2023-03-31 | $1,552 |
2022-12-31 | $1,562 |
2022-09-30 | $1,629 |
2022-06-30 | $1,719 |
2022-03-31 | $1,615 |
2021-12-31 | $1,685 |
2021-09-30 | $1,766 |
2021-06-30 | $1,743 |
2021-03-31 | $1,697 |
2020-12-31 | $1,672 |
2020-09-30 | $1,624 |
2020-06-30 | $1,588 |
2020-03-31 | $1,549 |
2019-12-31 | $1,615 |
2019-09-30 | $1,642 |
2019-06-30 | $1,709 |
2019-03-31 | $1,763 |
2018-12-31 | $1,791 |
2018-09-30 | $1,789 |
2018-06-30 | $1,810 |
2018-03-31 | $1,823 |
2017-12-31 | $1,844 |
2017-09-30 | $2,089 |
2017-06-30 | $2,107 |
2017-03-31 | $2,107 |
2016-12-31 | $2,092 |
2016-09-30 | $2,105 |
2016-06-30 | $2,016 |
2016-03-31 | $1,998 |
2015-12-31 | $1,980 |
2015-09-30 | $1,969 |
2015-06-30 | $827 |
2015-03-31 | $813 |
2014-12-31 | $836 |
2014-09-30 | $887 |
2014-06-30 | $913 |
2014-03-31 | $831 |
2013-12-31 | $873 |
2013-09-30 | $868 |
2013-06-30 | $312 |
2013-03-31 | $320 |
2012-12-31 | $179 |
2012-09-30 | $146 |
2012-06-30 | $152 |
2012-03-31 | $155 |
2011-12-31 | $161 |
2011-09-30 | $102 |
2011-06-30 | $111 |
2011-03-31 | $124 |
2010-12-31 | $23 |
2010-09-30 | $20 |
2010-06-30 | $50 |
2010-03-31 | $56 |
2009-12-31 | $32 |
2009-09-30 | $64 |
2009-06-30 | $39 |
2009-03-31 | $-8 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.078B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $196.322B | 23.95 |
Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
Alcon (ALC) | Switzerland | $42.414B | 28.38 |
Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
DexCom (DXCM) | United States | $28.447B | 42.84 |
Waters (WAT) | United States | $22.175B | 32.79 |
STERIS (STE) | Ireland | $21.157B | 24.36 |
SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
Hologic (HOLX) | United States | $18.343B | 19.35 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
Sysmex ADR (SSMXY) | Japan | $12.946B | 0.00 |
Globus Medical (GMED) | United States | $11.536B | 29.21 |
Penumbra (PEN) | United States | $9.397B | 92.04 |
Masimo (MASI) | United States | $9.260B | 44.81 |
Teleflex (TFX) | United States | $8.904B | 14.20 |
Glaukos (GKOS) | United States | $7.940B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
Veracyte (VCYT) | United States | $3.068B | 92.07 |
Inari Medical (NARI) | United States | $2.907B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
TransMedics (TMDX) | United States | $2.552B | 80.89 |
Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
Tandem Diabetes Care (TNDM) | United States | $2.023B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.820B | 9.51 |
RxSight (RXST) | United States | $1.807B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
Artivion (AORT) | United States | $1.185B | 78.53 |
Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
Paragon 28 (FNA) | United States | $0.841B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
IRadimed (IRMD) | United States | $0.675B | 36.46 |
OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
AxoGen (AXGN) | United States | $0.587B | 0.00 |
SiBone (SIBN) | United States | $0.527B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
Semler Scientific (SMLR) | United States | $0.463B | 31.05 |
Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
CVRx (CVRX) | United States | $0.360B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
NeuroPace (NPCE) | United States | $0.290B | 0.00 |
AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
Inogen (INGN) | United States | $0.223B | 0.00 |
Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
Accuray (ARAY) | United States | $0.194B | 0.00 |
Nevro (NVRO) | United States | $0.169B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
908 Devices (MASS) | United States | $0.089B | 0.00 |
LENSAR (LNSR) | United States | $0.086B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
Hyperfine (HYPR) | United States | $0.074B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
InspireMD (NSPR) | Israel | $0.069B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
Envoy Medical (COCH) | United States | $0.044B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
DarioHealth (DRIO) | United States | $0.029B | 0.00 |
Neuronetics (STIM) | United States | $0.027B | 0.00 |
NexGel (NXGL) | United States | $0.023B | 0.00 |
Spectral AI (MDAI) | United States | $0.022B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.008B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
Nuwellis (NUWE) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |